An overview on small molecule-induced differentiation of mesenchymal stem cells into beta cells for diabetic therapy
<div><p>The field of regenerative medicine provides enormous opportunities for generating beta cells from different stem cell sources for cellular therapy. Even though insulin-secreting cells can be generated from a variety of stem cell types like pluripotent stem cells and embryonic ste...
محفوظ في:
| المؤلف الرئيسي: | |
|---|---|
| مؤلفون آخرون: | , , , , |
| منشور في: |
2019
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
| _version_ | 1864513513989341184 |
|---|---|
| author | Nimshitha Pavathuparambil Abdul Manaph (17870420) |
| author2 | Kisha N. Sivanathan (5502359) Jodie Nitschke (93866) Xin-Fu Zhou (41165) Patrick T. Coates (5502365) Christopher John Drogemuller (18618376) |
| author2_role | author author author author author |
| author_facet | Nimshitha Pavathuparambil Abdul Manaph (17870420) Kisha N. Sivanathan (5502359) Jodie Nitschke (93866) Xin-Fu Zhou (41165) Patrick T. Coates (5502365) Christopher John Drogemuller (18618376) |
| author_role | author |
| dc.creator.none.fl_str_mv | Nimshitha Pavathuparambil Abdul Manaph (17870420) Kisha N. Sivanathan (5502359) Jodie Nitschke (93866) Xin-Fu Zhou (41165) Patrick T. Coates (5502365) Christopher John Drogemuller (18618376) |
| dc.date.none.fl_str_mv | 2019-09-23T03:00:00Z |
| dc.identifier.none.fl_str_mv | 10.1186/s13287-019-1396-5 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/journal_contribution/An_overview_on_small_molecule-induced_differentiation_of_mesenchymal_stem_cells_into_beta_cells_for_diabetic_therapy/25907224 |
| dc.rights.none.fl_str_mv | CC BY 4.0 info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Biomedical and clinical sciences Medical biotechnology Beta cells Mesenchymal stem cells Small molecules Differentiation Transplantation Therapy |
| dc.title.none.fl_str_mv | An overview on small molecule-induced differentiation of mesenchymal stem cells into beta cells for diabetic therapy |
| dc.type.none.fl_str_mv | Text Journal contribution info:eu-repo/semantics/publishedVersion text contribution to journal |
| description | <div><p>The field of regenerative medicine provides enormous opportunities for generating beta cells from different stem cell sources for cellular therapy. Even though insulin-secreting cells can be generated from a variety of stem cell types like pluripotent stem cells and embryonic stem cells, the ideal functional cells should be generated from patients’ own cells and expanded to considerable levels by non-integrative culture techniques. In terms of the ease of isolation, plasticity, and clinical translation to generate autologous cells, mesenchymal stem cell stands superior. Furthermore, small molecules offer a great advantage in terms of generating functional beta cells from stem cells. Research suggests that most of the mesenchymal stem cell-based protocols to generate pancreatic beta cells have small molecules in their cocktail. However, most of the protocols generate cells that mimic the characteristics of human beta cells, thereby generating “beta cell-like cells” as opposed to mature beta cells. Diabetic therapy becomes feasible only when there are robust, functional, and safe cells for replacing the damaged or lost beta cells. In this review, we discuss the current protocols used to generate beta cells from mesenchymal cells, with emphasis on small molecule-mediated conversion into insulin-producing beta cell-like cells. Our data and the data presented from the references within this review would suggest that although mesenchymal stem cells are an attractive cell type for cell therapy they are not readily converted into functional mature beta cells.</p><p> </p></div><h2>Other Information</h2> <p> Published in: Stem Cell Research & Therapy<br> License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1186/s13287-019-1396-5" target="_blank">https://dx.doi.org/10.1186/s13287-019-1396-5</a></p> |
| eu_rights_str_mv | openAccess |
| id | Manara2_e10f864ce3fa229821351c02b18e6c22 |
| identifier_str_mv | 10.1186/s13287-019-1396-5 |
| network_acronym_str | Manara2 |
| network_name_str | Manara2 |
| oai_identifier_str | oai:figshare.com:article/25907224 |
| publishDate | 2019 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY 4.0 |
| spelling | An overview on small molecule-induced differentiation of mesenchymal stem cells into beta cells for diabetic therapyNimshitha Pavathuparambil Abdul Manaph (17870420)Kisha N. Sivanathan (5502359)Jodie Nitschke (93866)Xin-Fu Zhou (41165)Patrick T. Coates (5502365)Christopher John Drogemuller (18618376)Biomedical and clinical sciencesMedical biotechnologyBeta cellsMesenchymal stem cellsSmall moleculesDifferentiationTransplantationTherapy<div><p>The field of regenerative medicine provides enormous opportunities for generating beta cells from different stem cell sources for cellular therapy. Even though insulin-secreting cells can be generated from a variety of stem cell types like pluripotent stem cells and embryonic stem cells, the ideal functional cells should be generated from patients’ own cells and expanded to considerable levels by non-integrative culture techniques. In terms of the ease of isolation, plasticity, and clinical translation to generate autologous cells, mesenchymal stem cell stands superior. Furthermore, small molecules offer a great advantage in terms of generating functional beta cells from stem cells. Research suggests that most of the mesenchymal stem cell-based protocols to generate pancreatic beta cells have small molecules in their cocktail. However, most of the protocols generate cells that mimic the characteristics of human beta cells, thereby generating “beta cell-like cells” as opposed to mature beta cells. Diabetic therapy becomes feasible only when there are robust, functional, and safe cells for replacing the damaged or lost beta cells. In this review, we discuss the current protocols used to generate beta cells from mesenchymal cells, with emphasis on small molecule-mediated conversion into insulin-producing beta cell-like cells. Our data and the data presented from the references within this review would suggest that although mesenchymal stem cells are an attractive cell type for cell therapy they are not readily converted into functional mature beta cells.</p><p> </p></div><h2>Other Information</h2> <p> Published in: Stem Cell Research & Therapy<br> License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1186/s13287-019-1396-5" target="_blank">https://dx.doi.org/10.1186/s13287-019-1396-5</a></p>2019-09-23T03:00:00ZTextJournal contributioninfo:eu-repo/semantics/publishedVersiontextcontribution to journal10.1186/s13287-019-1396-5https://figshare.com/articles/journal_contribution/An_overview_on_small_molecule-induced_differentiation_of_mesenchymal_stem_cells_into_beta_cells_for_diabetic_therapy/25907224CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/259072242019-09-23T03:00:00Z |
| spellingShingle | An overview on small molecule-induced differentiation of mesenchymal stem cells into beta cells for diabetic therapy Nimshitha Pavathuparambil Abdul Manaph (17870420) Biomedical and clinical sciences Medical biotechnology Beta cells Mesenchymal stem cells Small molecules Differentiation Transplantation Therapy |
| status_str | publishedVersion |
| title | An overview on small molecule-induced differentiation of mesenchymal stem cells into beta cells for diabetic therapy |
| title_full | An overview on small molecule-induced differentiation of mesenchymal stem cells into beta cells for diabetic therapy |
| title_fullStr | An overview on small molecule-induced differentiation of mesenchymal stem cells into beta cells for diabetic therapy |
| title_full_unstemmed | An overview on small molecule-induced differentiation of mesenchymal stem cells into beta cells for diabetic therapy |
| title_short | An overview on small molecule-induced differentiation of mesenchymal stem cells into beta cells for diabetic therapy |
| title_sort | An overview on small molecule-induced differentiation of mesenchymal stem cells into beta cells for diabetic therapy |
| topic | Biomedical and clinical sciences Medical biotechnology Beta cells Mesenchymal stem cells Small molecules Differentiation Transplantation Therapy |